| Bioactivity | Yimitasvir (Emitasvir) is an orally active hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor. Yimitasvir can be used for research of chronic HCV infection[1]. |
| Name | Yimitasvir |
| CAS | 1959593-23-7 |
| Formula | C49H58N8O6 |
| Molar Mass | 855.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huiying Rao, et al. Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis. J Clin Transl Hepatol. 2020 Sep 28;8(3):255-261 |
Yimitasvir
CAS: 1959593-23-7 F: C49H58N8O6 W: 855.03
Yimitasvir (Emitasvir) is an orally active hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor. Yimitasvir
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.